In conclusion, our study found that LRRFIP1 was highly expressed in pancreatic cancer, that high LRRFIP1 expression was associated with poor overall survival and that LRRFIP1 was correlated with immune cell infiltration in pancreatic cancer. The gene discussed is LRRFIP1; the disease is familial pancreatic carcinoma.